Cardiology

TRACK SRL

Sirolimus Eluting Coronary Stent  (SRL)

• L 605 cobalt-chromium stent platform with open and closed cell design.
• Unique stent design and strut locking mechanism offers excellent radial strength and minimal recoil.
• Uniform neointimal coverage and improved stent apposition.
• Completely biodegradable, biocompatible polymer (PLA carrier) 2 -Loading dose density of 1.20 g/mm
• 3 m - uniform coating thickness with precisely programmed release kinetics.
• Complete endothelization within180 days for drug release. In presence of drug how complete endothelialization happened.
• 90% of sirolimus is released within 90 to 120 days.
• Inhibits in-stent restenosis (ISR) and late stent thrombosis with adequate re- endothelialization.
• Designed for utmost safety - Track SRL displays one of the lowest entry profiles.
• Hydrophilic coated stent delivery system.